⌘K

Login Start Free

Home/Filings/4/0000950170-24-101432

4//SEC Filing

SCHAEFFER LEONARD D 4

Accession 0000950170-24-101432

CIK 0001604950other

View on SEC.gov Company Profile

Filed

Aug 27, 8:00 PM ET

Accepted

Aug 28, 4:30 PM ET

Size

9.8 KB

Accession

0000950170-24-101432

Insider Transaction Report

Form 4

Period: 2024-08-26

scPharmaceuticals Inc.SCPH

SCHAEFFER LEONARD D

Director

Transactions

Exercise/Conversion
Common Stock
2024-08-26$3.37/sh+6,124$20,638→ 54,451 total
Exercise/Conversion
Stock Option (Right to Buy)
2024-08-26−6,124→ 0 total
Exercise: $3.37Exp: 2029-06-18→ Common Stock (6,124 underlying)
Exercise/Conversion
Common Stock
2024-08-26$1.66/sh+5,223$8,670→ 48,327 total
Exercise/Conversion
Stock Option (Right to Buy)
2024-08-26−5,223→ 0 total
Exercise: $1.66Exp: 2024-09-17→ Common Stock (5,223 underlying)

Footnotes (1)

[F1]The option is fully vested.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

scPharmaceuticals Inc.

CIK 0001604950

Entity typeother

Related Parties

1

filerCIK 0001016369

Filing Metadata

Form type: 4
Filed: Aug 27, 8:00 PM ET
Accepted: Aug 28, 4:30 PM ET
Size: 9.8 KB

View on SEC.gov